CIK 0001297184
- Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 330702205
- Phone
- +1 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,562,744
- in 5 filings, $1.2M under 10b5-1 plans
Net −$1,562,744. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-30 | PETERS WILLIAM J CFO, SVP & Treasurer | Sale | −4,297 | $16.93 | $73K | 86,522 |
| 2017-05-11 | PRINS RICHARD K Director | Sale | −7,500 | $15.43 | $116K | 23,000 |
| 2017-01-03 | Petersen Floyd F. Director | Sale | −400 | $18.61 | $7K | 58,717 |
| 2016-12-15 | Gerst Diane G. EVP, QA & Regulatory Affairs | Sale | −2,940 | $20.51 | $60K | 26,195 |
| 2016-12-05 | Zhou Rong EVP, Production Center | Sale | −61 | $20.70 | $1K | 36,991 |
| 2016-12-01 | Petersen Floyd F. Director | Sale | −400 | $20.26 | $8K | 59,117 |
| 2016-11-28 | Shandell Jason B. President and General Counsel | Sale | −24,292 | $20.47 | $497K | 202,961 |
| 2016-11-25 | Shandell Jason B. President and General Counsel | Sale | −2,043 | $20.59 | $42K | 202,961 |
| 2016-11-15 | Lee Howard Director | Sale | −17,994 | $20.76 | $374K | 114,527 |
| 2016-11-14 | Lee Howard Director | Sale | −20,000 | $20.56 | $411K | 114,527 |
| 2016-11-11 | PRINS RICHARD K Director | Sale | −8,000 | $20.06 | $161K | 23,000 |
| 2016-11-01 | Petersen Floyd F. Director | Sale | −400 | $18.09 | $7K | 59,517 |
| 2016-10-03 | Petersen Floyd F. Director | Sale | −400 | $18.75 | $8K | 59,917 |
| 2016-09-26 | Shandell Jason B. President and General Counsel | Sale | −56,996 | $19.50 | $1.1M | 202,961 |
| 2016-09-21 | Zhang Jack Y. CEO & Chief Science Officer | Sale | −54,581 | $20.70 | $1.1M | 1,088,835 |
| 2016-09-21 | Zhang Jack Y. CEO & Chief Science Officer | Sale | −500 | $21.45 | $11K | 1,088,335 |
| 2016-09-20 | Zhang Jack Y. CEO & Chief Science Officer | Sale | −76,152 | $20.73 | $1.6M | 1,219,533 |
| 2016-09-20 | Zhang Jack Y. CEO & Chief Science Officer | Sale | −131,198 | $21.33 | $2.8M | 1,088,335 |
| 2016-09-20 | Zhang Jack Y. CEO & Chief Science Officer | Sale | −86,555 | $20.74 | $1.8M | 847,534 |
| 2016-09-20 | Zhang Jack Y. CEO & Chief Science Officer | Sale | −95,213 | $21.33 | $2.0M | 752,321 |
Page 20 of 24 · 480 trades